moxifloxacin has been researched along with Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansari, Y; Capewell, N; Hui, BTK; Liu, X | 1 |
| Font Juliá, E; Hernández Pardines, F; Molina Martin, JC; Serra Verdú, MC | 1 |
2 other study(ies) available for moxifloxacin and Atrophy
| Article | Year |
|---|---|
Bilateral acute anterior uveitis and iris atrophy caused by moxifloxacin.
Topics: Acute Disease; Anti-Bacterial Agents; Atrophy; Humans; Iris; Male; Middle Aged; Moxifloxacin; Mydriasis; Pneumonia; Tomography, Optical Coherence; Treatment Outcome; Uveitis, Anterior | 2020 |
Aqueous humor misdirection syndrome after glaucoma filtering surgery in patient with bilateral acute iris transillumination (BAIT) syndrome.
Topics: Anti-Inflammatory Agents; Aqueous Humor; Atrophy; Combined Modality Therapy; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Iridectomy; Iris; Laser Therapy; Middle Aged; Moxifloxacin; Mydriasis; Phacoemulsification; Postoperative Complications; Prednisone; Syndrome; Trabeculectomy; Vitrectomy | 2018 |